133 related articles for article (PubMed ID: 31730256)
1. Efficacy of intravenous immunoglobulins for laryngopharyngeal lesions and upper airway obstruction in epidermolysis bullosa acquisita.
Komatsu-Fujii T; Honda T; Tahara J; Yamashita C; Oguma T; Dainichi T; Kabashima K
J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):e131-e133. PubMed ID: 31730256
[No Abstract] [Full Text] [Related]
2. Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins.
Mohr C; Sunderkötter C; Hildebrand A; Biel K; Rütter A; Rütter GH; Luger TA; Kolde G
Br J Dermatol; 1995 May; 132(5):824-6. PubMed ID: 7772494
[TBL] [Abstract][Full Text] [Related]
3. Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins.
Caldwell JB; Yancey KB; Engler RJ; James WD
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):827-8. PubMed ID: 7929940
[No Abstract] [Full Text] [Related]
4. Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins.
Meier F; Sönnichsen K; Schaumburg-Lever G; Dopfer R; Rassner G
J Am Acad Dermatol; 1993 Aug; 29(2 Pt 2):334-7. PubMed ID: 8340508
[TBL] [Abstract][Full Text] [Related]
5. Severe, refractory epidermolysis bullosa acquisita complicated by an oesophageal stricture responding to intravenous immune globulin.
Harman KE; Whittam LR; Wakelin SH; Black MM
Br J Dermatol; 1998 Dec; 139(6):1126-7. PubMed ID: 9990396
[No Abstract] [Full Text] [Related]
6. Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins.
Gourgiotou K; Exadaktylou D; Aroni K; Rallis E; Nicolaidou E; Paraskevakou H; Katsambas AD
J Eur Acad Dermatol Venereol; 2002 Jan; 16(1):77-80. PubMed ID: 11952298
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita.
Kofler H; Wambacher-Gasser B; Topar G; Weinlich G; Schuler G; Hintner H; Romani N; Fritsch P
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):331-5. PubMed ID: 9039213
[TBL] [Abstract][Full Text] [Related]
8. Emerging treatment for epidermolysis bullosa acquisita.
Engineer L; Ahmed AR
J Am Acad Dermatol; 2001 May; 44(5):818-28. PubMed ID: 11312431
[TBL] [Abstract][Full Text] [Related]
9. Epidermolysis bullosa acquisita--a case with upper airways obstruction requiring tracheostomy and responding to cyclosporin.
Clement M; Ratnesar P; Thirumoorthy T; McGrath J; Black MM
Clin Exp Dermatol; 1993 Nov; 18(6):548-51. PubMed ID: 8252795
[TBL] [Abstract][Full Text] [Related]
10. Epidermolysis bullosa acquisita and multiple myeloma.
Engineer L; Dow EC; Braverman IM; Ahmed AR
J Am Acad Dermatol; 2002 Dec; 47(6):943-6. PubMed ID: 12451384
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenous immunoglobulins for the treatment of mucous membrane pemphigoid-like epidermolysis bullosa acquisita.
Komori T; Dainichi T; Kusuba N; Otsuka A; Hashimoto T; Kabashima K
Eur J Dermatol; 2017 Oct; 27(5):563-564. PubMed ID: 29084648
[No Abstract] [Full Text] [Related]
12. Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita.
Tayal U; Burton J; Dash C; Wojnarowska F; Chapel H
Clin Immunol; 2008 Dec; 129(3):518-9. PubMed ID: 18848500
[No Abstract] [Full Text] [Related]
13. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita.
Letko E; Bhol K; Anzaar F; Perez VL; Ahmed AR; Foster CS
Arch Ophthalmol; 2006 Nov; 124(11):1615-8. PubMed ID: 17102010
[TBL] [Abstract][Full Text] [Related]
14. Laryngeal manifestations of epidermolysis bullosa acquisita.
Hester JE; Arnstein DP; Woodley D
Arch Otolaryngol Head Neck Surg; 1995 Sep; 121(9):1042-4. PubMed ID: 7646856
[TBL] [Abstract][Full Text] [Related]
15. Fatal vascular involvement in systemic lupus erythematosus following epidermolysis bullosa acquisita.
Yoon J; Moon TK; Lee KH; Kim SC
Acta Derm Venereol; 1995 Mar; 75(2):143-6. PubMed ID: 7604645
[TBL] [Abstract][Full Text] [Related]
16. Management of epidermolysis bullosa acquisita.
Intong LR; Murrell DF
Dermatol Clin; 2011 Oct; 29(4):643-7. PubMed ID: 21925011
[TBL] [Abstract][Full Text] [Related]
17. Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up.
Ahmed AR; Gürcan HM
J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1074-83. PubMed ID: 21819451
[TBL] [Abstract][Full Text] [Related]
18. [Epidermolysis bullosa acquisita: literature review].
Le Roux-Villet C; Prost-Squarcioni C
Ann Dermatol Venereol; 2011 Mar; 138(3):228-46. PubMed ID: 21397153
[TBL] [Abstract][Full Text] [Related]
19. [Epidermolysis bullosa acquisita. Guidelines for the diagnosis and treatment. Centres de référence des maladies bulleuses auto-immunes. Société Française de Dermatologie].
Prost-Squarcioni C; Ingen-Housz-Oro S; Joly P; Bernard P; Bedane C;
Ann Dermatol Venereol; 2011 Mar; 138(3):274-9. PubMed ID: 21397160
[No Abstract] [Full Text] [Related]
20. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases.
Segura S; Iranzo P; Martínez-de Pablo I; Mascaró JM; Alsina M; Herrero J; Herrero C
J Am Acad Dermatol; 2007 Jun; 56(6):960-7. PubMed ID: 17368865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
